In the 1950s, nothing much could be done for patients with acute lymphoblastic leukemia (ALL). Dr. Jim Holland was determined to change that.

“It’s so important to have conversations with patients when they do have a life-limiting illness. It is the only way to ensure that patients and their families are prepared and that their wishes regarding end-of-life care are honored.”

On January 29, the Food and Drug Administration approved a lutetium Lu 177 dotatate (Lutathera^®), a targeted radiation drug, for the treatment of gastroenteropancreatic neuroendocrine tumors.

The idea of building a cancer hospital in Buffalo first came to light just three years after Dr. Roswell Park opened the doors to the world’s first cancer research laboratory.

In 1990, during my nursing clinical rotation here at Roswell Park, I declared, “This is it. This is where I want to work.” Nearly 28 years later, I am still here and still look forward to coming to work every day.